Report Code: 12275 | Available Format: PDF | Pages: 233
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Analysis Period
1.4 Market Data Reporting Unit
1.4.1 Value
1.5 Research Scope
1.5.1 Market Segmentation by Type
1.5.2 Market Segmentation by Product Type
1.5.3 Market Segmentation by Region
1.5.4 Market Segment Analysis of Countries
1.6 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.1.3 P&S Intelligence Database
2.2 Primary Research
2.2.1 Breakdown of Primary Research, by Region
2.2.2 Breakdown of Primary Research, by Industry Participant
2.2.3 Breakdown of Primary Research, by Designation
2.2.4 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Market Share Research Methodology
2.7 Assumptions for the Study
2.8 Notes & Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
5.1 Increasing Geriatric Population
Chapter 6. Definition of Market Segments
6.1 By Type
6.1.1 Coronary
6.1.2 Peripheral
6.2 By Product Type
6.2.1 Catheter
6.2.2 Guidewire
6.2.3 Embolic Protection Device
6.2.4 IVC Filter
6.2.5 Sheath
6.2.6 Vascular Closure System
6.2.7 Vascular Patch
6.2.8 Vascular Plug
6.2.9 Others
Chapter 7. Industry Outlook
7.1 Market Dynamics
7.1.1 Trends
7.1.1.1 Mergers and acquisitions
7.1.1.2 Product launches
7.1.2 Drivers
7.1.2.1 High healthcare expenditure and early adoption of interventional radiology procedures
7.1.2.2 Increasing demand for vascular interventional procedures among geriatric population
7.1.2.3 Strong interventional vascular consumables supply chain
7.1.3 Impact Analysis of Drivers on Market Forecast
7.1.4 Restraints
7.1.4.1 High pricing and complex manufacturing
7.1.5 Impact Analysis of Restraints on Market Forecast
7.2 Impact of COVID-19
7.3 Porter’s Five Forces Analysis
7.3.1 Bargaining Power of Buyers
7.3.2 Bargaining Power of Suppliers
7.3.3 Intensity of Rivalry
7.3.4 Threat of New Entrants
7.3.5 Threat of Substitutes
Chapter 8. Global Market Size and Forecast
8.1 Overview
8.2 Market Revenue, by Type (2015–2030)
8.3 Market Revenue, by, Product Type (2015–2030)
8.4 Market Revenue, by Region (2015–2030)
Chapter 9. North America Market Size and Forecast
9.1 Overview
9.1.1 Entry Barriers
9.1.1.1 Stringent government regulations
9.1.1.2 Consolidated market nature
9.2 Market Revenue, by Type (2015–2030)
9.3 Market Revenue, by, Product Type (2015–2030)
9.4 Market Revenue, by Country (2015–2030)
Chapter 10. Europe Market Size and Forecast
10.1 Overview
10.1.1 Entry Barriers
10.1.1.1 New regulations leading to more-stringent medical device approval procedures
10.1.1.2 Brand identity
10.2 Market Revenue, by Type (2015–2030)
10.3 Market Revenue, by, Product Type (2015–2030)
10.4 Market Revenue, by Country (2015–2030)
Chapter 11. APAC Market Size and Forecast
11.1 Overview
11.2 Market Revenue, by Type (2015–2030)
11.3 Market Revenue, by, Product Type (2015–2030)
11.4 Market Revenue, by Country (2015–2030)
Chapter 12. LATAM Market Size and Forecast
12.1 Overview
12.2 Market Revenue, by Type (2015–2030)
12.3 Market Revenue, by, Product Type (2015–2030)
12.4 Market Revenue, by Country (2015–2030)
Chapter 13. MEA Market Size and Forecast
13.1 Overview
13.2 Market Revenue, by Type (2015–2030)
13.3 Market Revenue, by, Product Type (2015–2030)
13.4 Market Revenue, by Country (2015–2030)
Chapter 14. U.S. Market Size and Forecast
14.1 Market Revenue, by Type (2015–2030)
14.2 Market Revenue, by, Product Type (2015–2030)
Chapter 15. Canada Market Size and Forecast
15.1 Market Revenue, by Type (2015–2030)
15.2 Market Revenue, by, Product Type (2015–2030)
Chapter 16. Germany Market Size and Forecast
16.1 Market Revenue, by Type (2015–2030)
16.2 Market Revenue, by, Product Type (2015–2030)
Chapter 17. France Market Size and Forecast
17.1 Market Revenue, by Type (2015–2030)
17.2 Market Revenue, by, Product Type (2015–2030)
Chapter 18. U.K. Market Size and Forecast
18.1 Market Revenue, by Type (2015–2030)
18.2 Market Revenue, by, Product Type (2015–2030)
Chapter 19. Italy Market Size and Forecast
19.1 Market Revenue, by Type (2015–2030)
19.2 Market Revenue, by, Product Type (2015–2030)
Chapter 20. Spain Market Size and Forecast
20.1 Market Revenue, by Type (2015–2030)
20.2 Market Revenue, by, Product Type (2015–2030)
Chapter 21. Competitive Landscape
21.1 Company Share Analysis
21.1.1 Global
21.1.2 U.S.
21.1.3 Europe
21.2 List of Products Offered by Key Player
21.3 Recent Strategic Developments of Key Players
21.3.1 Mergers and Acquisitions
21.3.2 Product Launches and Approvals
21.3.3 Others Developments
Chapter 22. Company Profiles
22.1 Hugo Kern und Liebers GmbH & Co. KG
22.1.1 Business Overview
22.1.2 Product and Service Offerings
22.2 Integer Holdings Corporation
22.2.1 Business Overview
22.2.2 Product and Service Offerings
22.2.3 Key Financial Summary
22.3 HEXACATH
22.3.1 Business Overview
22.3.2 Product and Service Offerings
22.4 Eurocor Tech GmbH
22.4.1 Business Overview
22.4.2 Product and Service Offerings
22.5 REX MEDICAL L.P.
22.5.1 Business Overview
22.5.2 Product and Service Offerings
22.6 ArtVentive Medical Group Inc.
22.6.1 Business Overview
22.6.2 Product and Service Offerings
22.7 Balton Sp. z o. o.
22.7.1 Business Overview
22.7.2 Product and Service Offerings
22.8 Cardiva Medical Inc.
22.8.1 Business Overview
22.8.2 Product and Service Offerings
22.9 Medtronic plc
22.9.1 Business Overview
22.9.2 Product and Service Offerings
22.9.3 Key Financial Summary
22.10 B. Braun Melsungen AG
22.10.1 Business Overview
22.10.2 Product and Service Offerings
22.10.3 Key Financial Summary
22.11 Becton, Dickinson and Company
22.11.1 Business Overview
22.11.2 Product and Service Offerings
22.11.3 Key Financial Summary
22.12 Biosensors International Group Ltd.
22.12.1 Business Overview
22.12.2 Product and Service Offerings
22.13 Abbott Laboratories
22.13.1 Business Overview
22.13.2 Product and Service Offerings
22.13.3 Key Financial Summary
22.14 Johnson & Johnson
22.14.1 Business Overview
22.14.2 Products and Service Offerings
22.14.3 Key Financial Summary
22.15 Confluent Medical Technologies
22.15.1 Business Overview
22.15.2 Product and Service Offerings
22.16 Heraeus Holdings GmbH
22.16.1 Business Overview
22.16.2 Product and Service Offerings
22.17 Lemaitre Vascular Inc.
22.17.1 Business Overview
22.17.2 Product and Service Offerings
22.17.3 Key Financial Summary
22.18 PRODIMED
22.18.1 Business Overview
22.18.2 Product and Service Offerings
22.19 GALT MEDICAL Corp.
22.19.1 Business Overview
22.19.2 Product and Service Offerings
22.20 Vygon SA
22.20.1 Business Overview
22.20.2 Product and Service Offerings
22.21 Terumo Corporation
22.21.1 Business Overview
22.21.2 Product and Service Offerings
22.21.3 Key Financial Summary
22.22 Merit Medical Systems Inc.
22.22.1 Business Overview
22.22.2 Product and Service Offerings
22.22.3 Key Financial Summary
22.23 Argon Medical Devices Inc.
22.23.1 Business Overview
22.23.2 Product and Service Offerings
22.24 Cardinal Health Inc.
22.24.1 Business Overview
22.24.2 Product and Service Offerings
22.24.3 Key Financial Summary
22.25 Boston Scientific Corporation
22.25.1 Business Overview
22.25.2 Product and Service Offerings
22.25.3 Key Financial Summary
22.26 Cook Medical LLC
22.26.1 Business Overview
22.26.2 Product and Service Offerings
Chapter 23. Appendix
23.1 Abbreviations
23.2 Sources and References
23.3 Related Reports
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 5 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 6 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 7 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 8 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 9 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 10 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY REGION, $M (2015–2021)
TABLE 11 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY REGION, $M (2022–2026)
TABLE 12 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY REGION, $M (2027–2030)
TABLE 13 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 14 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 15 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 16 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 17 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 18 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 19 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2015–2021)
TABLE 20 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2022–2026)
TABLE 21 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 22 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 23 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 24 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 25 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 26 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 27 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 28 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2015–2021)
TABLE 29 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2022–2026)
TABLE 30 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 31 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 32 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 33 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 34 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 35 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 36 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 37 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2015–2021)
TABLE 38 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2022–2026)
TABLE 39 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 40 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 41 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 42 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 43 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 44 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 45 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 46 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2015–2021)
TABLE 47 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2022–2026)
TABLE 48 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 49 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 50 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 51 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 52 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 53 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 54 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 55 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2015–2021)
TABLE 56 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2022–2026)
TABLE 57 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 58 U.S. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 59 U.S. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 60 U.S. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 61 U.S. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 62 U.S. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 63 U.S. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 64 CANADA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 65 CANADA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 66 CANADA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 67 CANADA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 68 CANADA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 69 CANADA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 70 GERMANY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 71 GERMANY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 72 GERMANY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 73 GERMANY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 74 GERMANY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 75 GERMANY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 76 FRANCE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 77 FRANCE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 78 FRANCE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 79 FRANCE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 80 FRANCE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 81 FRANCE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 82 U.K. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 83 U.K. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 84 U.K. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 85 U.K. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 86 U.K. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 87 U.K. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 88 ITALY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 89 ITALY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 90 ITALY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 91 ITALY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 92 ITALY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 93 ITALY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 94 SPAIN INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2021)
TABLE 95 SPAIN INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2022–2026)
TABLE 96 SPAIN INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 97 SPAIN INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2021)
TABLE 98 SPAIN INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2022–2026)
TABLE 99 SPAIN INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2027–2030)
TABLE 100 LIST OF PRODUCTS OFFERED BY KEY PLAYERS
TABLE 101 HUGO KERN UND LIEBERS GMBH & CO. KG – AT A GLANCE
TABLE 102 INTEGER HOLDINGS CORPORATION – AT A GLANCE
TABLE 103 INTEGER HOLDINGS CORPORATION – KEY FINANCIAL SUMMARY
TABLE 104 HEXACATH – AT A GLANCE
TABLE 105 EUROCOR TECH GMBH – AT A GLANCE
TABLE 106 REX MEDICAL L.P. – AT A GLANCE
TABLE 107 ARTVENTIVE MEDICAL GROUP INC. – AT A GLANCE
TABLE 108 BALTON SP. Z O. O. – AT A GLANCE
TABLE 109 CARDIVA MEDICAL INC. – AT A GLANCE
TABLE 110 MEDTRONIC PLC – AT A GLANCE
TABLE 111 MEDTRONIC PLC - KEY FINANCIAL SUMMARY
TABLE 112 B. BRAUN MELSUNGEN AG – AT A GLANCE
TABLE 113 B. BRAUN MELSUNGEN AG – KEY FINANCIAL SUMMARY
TABLE 114 BECTON, DICKINSON AND COMPANY – AT A GLANCE
TABLE 115 BECTON, DICKINSON AND COMPANY – KEY FINANCIAL SUMMARY
TABLE 116 BIOSENSORS INTERNATIONAL GROUP LTD. – AT A GLANCE
TABLE 117 ABBOTT LABORATORIES – AT A GLANCE
TABLE 118 ABBOTT LABORATORIES – KEY FINANCIAL SUMMARY
TABLE 119 JOHNSON & JOHNSON – AT A GLANCE
TABLE 120 JOHNSON & JOHNSON – KEY FINANCIAL SUMMARY
TABLE 121 CONFLUENT MEDICAL TECHNOLOGIES – AT A GLANCE
TABLE 122 HERAEUS HOLDINGS GMBH – AT A GLANCE
TABLE 123 LEMAITRE VASCULAR INC. – AT A GLANCE
TABLE 124 LEMAITRE VASCULAR INC. – KEY FINANCIAL SUMMARY
TABLE 125 PRODIMED – AT A GLANCE
TABLE 126 GALT MEDICAL CORP. – AT A GLANCE
TABLE 127 VYGON SA – AT A GLANCE
TABLE 128 TERUMO CORPORATION – AT A GLANCE
TABLE 129 TERUMO CORPORATION – KEY FINANCIAL SUMMARY
TABLE 130 MERIT MEDICAL SYSTEMS INC. – AT A GLANCE
TABLE 131 MERIT MEDICAL SYSTEMS INC. – KEY FINANCIAL SUMMARY
TABLE 132 ARGON MEDICAL DEVICES INC. – AT A GLANCE
TABLE 133 CARDINAL HEALTH INC. – AT A GLANCE
TABLE 134 CARDINAL HEALTH INC. – KEY FINANCIAL SUMMARY
TABLE 135 BOSTON SCIENTIFIC CORPORATION – AT A GLANCE
TABLE 136 BOSTON SCIENTIFIC COPORATION – KEY FINANCIAL SUMMARY
TABLE 158 COOK MEDICAL LLC – AT A GLANCE
LIST OF FIGURES
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
FIG 6 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET SUMMARY
FIG 9 VOICE OF INDUSTRY EXPERTS/KOLS
FIG 10 PERCENTAGE OF AGING POPULATION IN MAJOR REGIONS (2019 AND 2030)
FIG 11 BARGAINING POWER OF BUYERS
FIG 12 BARGAINING POWER OF SUPPLIERS
FIG 13 INTENSITY OF RIVALRY
FIG 14 THREAT OF NEW ENTRANTS
FIG 15 THREAT OF SUBSTITUTES
FIG 16 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET SNAPSHOT
FIG 17 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 18 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 19 MAJOR WORLDWIDE MARKETS FOR INTERVENTIONAL VASCULAR CONSUMABLES, $M
FIG 20 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY REGION, $M (2015–2030)
FIG 21 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET SNAPSHOT
FIG 22 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 23 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 24 NORTH AMERICA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2015–2030)
FIG 25 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET SNAPSHOT
FIG 26 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 27 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 28 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2015–2030)
FIG 29 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET SNAPSHOT
FIG 30 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 31 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 32 APAC INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2015–2030)
FIG 33 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET SNAPSHOT
FIG 34 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 35 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 36 LATAM INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2015–2030)
FIG 37 MEA INTERVENTIONAL VASCULAR CONSUMABLES SNAPSHOT
FIG 38 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 39 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 40 MEA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY COUNTRY, $M (2015–2030)
FIG 41 U.S. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 42 U.S. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 43 CANADA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 44 CANADA INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 45 GERMANY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 46 GERMANY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 47 FRANCE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 48 FRANCE INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 49 U.K. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 50 U.K. INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 51 ITALY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 52 ITALY INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 53 SPAIN INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY TYPE, $M (2015–2030)
FIG 54 SPAIN INTERVENTIONAL VASCULAR CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, $M (2015–2030)
FIG 55 GLOBAL INTERVENTIONAL VASCULAR CONSUMABLES MARKET SHARE OF KEY PLAYERS (2021)
FIG 56 U.S. INTERVENTIONAL VASCULAR CONSUMABLES MARKET SHARE OF KEY PLAYERS (2021)
FIG 57 EUROPE INTERVENTIONAL VASCULAR CONSUMABLES MARKET SHARE OF KEY PLAYERS (2021)
FIG 58 INTEGER HOLDINGS CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
FIG 59 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
FIG 60 B. BRAUN MELSUNGEN AG – REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2020)
FIG 61 BECTON, DICKINSON AND COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
FIG 62 ABBOTT LABORATORIES – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
FIG 63 JOHNSON & JOHNSON – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 64 LEMAITRE VASCULAR INC. – REVENUE SPLIT BY GEOGRAPHY (2021)
FIG 65 TERUMO CORPORATION – REVENUE SPLIT BY COMPANY AND GEOGRAPHY (2021)
FIG 66 MERIT MEDICAL SYSTEMS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
FIG 67 CARDINAL HEALTH INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
FIG 68 BOSTON SCIENTIFIC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
Get a bespoke market intelligence solution
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws